Chief Executive Officer

Head of Research and Development

Pheon Therapeutics Bolsters Board of Directors with Oncology R&D Expert Dr. Samuel Blackman

Day One Biopharmaceuticals initiated with bullish view at Piper Sandler, here's why

Day One Biopharmaceuticals reports Q2 EPS (29c), consensus (34c)

Why Astera Labs Shares Are Trading Higher By Over 17%; Here Are 20 Stocks Moving Premarket

Finance Community

Day One Biopharmaceuticals develops targeted therapies to treat people with life-threatening diseases. They are seeking candidates interested in Finance, Accounting, Corporate Development, Corporate Communications, or Information Technology for future consideration.

Sign up with Google

Sign in with Google